20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Imperva Inc (NYSE: IMPV) shares have rallied around 12 percent Tuesday following an SEC filing Monday afternoon which showed a new 9.8 percent stake by Elliott Associates.
Oppenheimer analyst Shual Eyal offered comments on Imperva Tuesday amid the filing.
"We have been long arguing that IMPV's current price does not fully reflect its market opportunity, growth potential, and genuine valuation. We continue to view IMPV as having a strong leadership position within the web application firewall (WAF), database activity monitoring (DAM) and file activity monitoring (FAM) market given a robust end-to-end platform (on-and-off premise) serving both the SMB and high-end markets," Eyal said.
"In a rapidly consolidating security environment, we view Elliott's stake as further affirmation of IMPV's LT potential valuation that could be further unlocked through strategic moves," the Oppenheimer analyst continued.
Eyal reiterated an Outperform rating and $60 price target on shares of Imperva.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!